Actively Recruiting

Age: 18Years - 99Years
All Genders
NCT06681051

Effectiveness and Safety of OSTENIL® TENDON in the Treatment of Pain and Restricted Mobility in Tendon Disorders

Led by TRB Chemedica AG · Updated on 2025-09-22

84

Participants Needed

5

Research Sites

96 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

PMCF study to further substantiate the effectiveness and safety of OSTENIL® TENDON in the overall as well as indication-specific treatment of pain and restricted mobility in four different tendon disorders (patella tendon, peroneal tendon, medial epicondylus humeri and iliotibial band) in a real-life clinical setting when used according to the instructions for use.

CONDITIONS

Official Title

Effectiveness and Safety of OSTENIL® TENDON in the Treatment of Pain and Restricted Mobility in Tendon Disorders

Who Can Participate

Age: 18Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient aged between 18 and 99 years
  • Diagnosis of symptomatic tendinopathy in patella tendon, peroneal tendon, medial epicondylus humeri, or iliotibial band
  • Physician's recommendation to use OSTENIL4 TENDON before recruitment
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Known hypersensitivity to any OSTENIL4 TENDON ingredients
  • Pregnancy or breastfeeding
  • Acute trauma
  • Local OSTENIL4 TENDON or other hyaluronic acid treatment within last 6 months
  • Local platelet-rich plasma treatment within last 3 months
  • Local corticosteroid treatment at any time
  • Local extracorporeal shock wave therapy within last 4 weeks
  • Local phytotherapy within last 4 weeks
  • Local surgical intervention at any time
  • Systemic corticosteroid treatment within last 4 weeks
  • Repeated use of NSAIDs or other analgesics within last week
  • Physiotherapy, ortheses, TENS, or acupuncture within last week
  • Chronic inflammatory disease diagnosis prior to inclusion
  • Participation in another clinical study within last 6 months
  • Vulnerable patient unable to fully understand or consent to study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

Orthopädische Gemeinschaftspraxis ÜBAG

Berlin, State of Berlin, Germany, 14195

Actively Recruiting

2

ATOS MVZ meviva Berlin

Berlin, Germany, 10627

Actively Recruiting

3

Orthopädie am Kiesteich

Berlin, Germany, 13589

Actively Recruiting

4

Orthopädie Dr. Bentzin

Berlin, Germany, 14197

Actively Recruiting

5

Orthopädische Praxis Dr. Fischer

Potsdam, Germany, 14482

Actively Recruiting

Loading map...

Research Team

R

Raphaela Geiger

CONTACT

V

Veronika Mussack, Dr.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here